Showing results (71-80 of 3,904) with videos related to
Sort By:
Pageof 391
American Journal of Cancer Research|July 11, 2022
Combined inhibition of FGFR4 and VEGFR signaling enhances efficacy in FGF19 driven hepatocellular carcinomaXuesong Zhao, Jaya Julie Joshi, Daniel Aird, et al.American Journal of Cancer Research|July 11, 2022
The clinical relevance of unfolded protein response signaling in breast cancerMasanori Oshi, Arya Mariam Roy, Shipra Gandhi, et al.American Journal of Cancer Research|July 11, 2022
Peruvoside is a novel Src inhibitor that suppresses NSCLC cell growth and motility by downregulating multiple Src-EGFR-related pathwaysYihua Lai, Hsiuhui Chang, Hueiwen Chen, et al.American Journal of Cancer Research|July 11, 2022
Ubiquitin specific peptidase 38 promotes the progression of gastric cancer through upregulation of fatty acid synthaseZhi Zheng, Yuxi Shang, Rui Xu, et al.American Journal of Cancer Research|July 11, 2022
Current status and future perspectives of immune checkpoint inhibitors in extensive-stage small cell lung cancerXingyu Liu, Huifang Xing, Baoxing LiuAmerican Journal of Cancer Research|July 11, 2022
Upregulation of CYP1B1 by hypoxia is mediated by ERα activation in breast cancer cellsJin Young Min, Gi Ho Lee, Tilak Khanal, et al.American Journal of Cancer Research|July 11, 2022
Adverse events of sorafenib in hepatocellular carcinoma treatmentYongsheng Pang, Aydin Eresen, Zigeng Zhang, et al.American Journal of Cancer Research|July 11, 2022
Effect of natural flavonoids to reverse P-glycoprotein-related multidrug resistance in breast cancer cell culturesMiglė Paškevičiūtė, Vilma PetrikaitėAmerican Journal of Cancer Research|May 21, 2019
A comprehensive review of Hep-2 cell line in translational research for laryngeal cancerPhilippe GorpheAmerican Journal of Cancer Research|May 21, 2019
The human positive cofactor 4 promotes androgen-independent prostate cancer development and progression through HIF-1α/β-catenin pathwayPeng Luo, Qingzhi Jiang, Qiang Fang, et al.Pageof 391